News 
Market Data 
Discover
Replies to post #60347 on Intellicell Biosciences Inc (fka SVFC)
Dr. Richard Burt, the chief or immunotherapy at Northwestern Memorial Hospital, and his team will use Burke's stem cells to reset her immune system.
"It generates an immune system that ends up -- in the process of doing that -- developing a tolerance to self which puts the disease in remission," Burt explained.
Burt has been performing the experimental procedure on humans since 2008. He said he sees only seven percent of patients relapse. Burt said he often finds insurance companies are willing to pay for the therapy.
"The majority of the time insurance does pay many of the major carriers pay. Medicare pays. Medicaid in the state of Illinois pays. It's a rare carrier that doesn't pay," Burt said.
Burke said her insurance will cover all of the $150,000 procedure. He called that a bargain, considering she is on 19 medications, one of which costs her insurance company $200,000 each year.
Burt said the stem cell therapy is best for patients like Burke with relapsing-remitting multiple sclerosis, which keeps getting worse.
